Libuse Zatloukalová

Title: Libuse Zatloukalová: Innovator in Pharmaceutical Composition

Introduction

Libuse Zatloukalová is a notable inventor based in Brno, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions with antitumor activity. His work is characterized by a focus on innovative solutions that address critical health challenges.

Latest Patents

Zatloukalová holds a patent for a pharmaceutical composition with antitumor activity based on carboplatin. This invention involves an aqueous solution of carboplatin with a content ranging from 1 to 20 mg·ml. The composition is designed to contain less than 0.1% by weight of 1,1-cyclobutanedicarboxylic acid (CBDCA) and/or its salt, based on the weight of the carboplatin present. This innovative approach aims to enhance the efficacy of carboplatin in cancer treatment.

Career Highlights

Zatloukalová is associated with Pliva-Lachema A.S., a company known for its contributions to the pharmaceutical industry. His work at this institution has allowed him to focus on research and development in the field of oncology. His dedication to improving pharmaceutical compositions has positioned him as a key figure in the industry.

Collaborations

Zatloukalová has collaborated with notable colleagues, including Vladimír Kysilka and Miroslav Maleček. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in pharmaceutical research.

Conclusion

Libuse Zatloukalová's contributions to pharmaceutical compositions demonstrate his commitment to advancing cancer treatment. His innovative work continues to impact the field positively, showcasing the importance of research and collaboration in developing effective medical solutions.